Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Pneumonia recovery reprograms the alveolar macrophage pool
Antoine Guillon, Emad I. Arafa, Kimberly A. Barker, Anna C. Belkina, Ian Martin, Anukul T. Shenoy, Alicia K. Wooten, Carolina Lyon De Ana, Anqi Dai, Adam Labadorf, Jaileene Hernandez Escalante, Hans Dooms, Hélène Blasco, Katrina E. Traber, Matthew R. Jones, Lee J. Quinton, Joseph P. Mizgerd
Antoine Guillon, Emad I. Arafa, Kimberly A. Barker, Anna C. Belkina, Ian Martin, Anukul T. Shenoy, Alicia K. Wooten, Carolina Lyon De Ana, Anqi Dai, Adam Labadorf, Jaileene Hernandez Escalante, Hans Dooms, Hélène Blasco, Katrina E. Traber, Matthew R. Jones, Lee J. Quinton, Joseph P. Mizgerd
View: Text | PDF
Research Article Pulmonology

Pneumonia recovery reprograms the alveolar macrophage pool

  • Text
  • PDF
Abstract

Community-acquired pneumonia is a widespread disease with significant morbidity and mortality. Alveolar macrophages are tissue-resident lung cells that play a crucial role in innate immunity against bacteria that cause pneumonia. We hypothesized that alveolar macrophages display adaptive characteristics after resolution of bacterial pneumonia. We studied mice 1 to 6 months after self-limiting lung infections with Streptococcus pneumoniae, the most common cause of bacterial pneumonia. Alveolar macrophages, but not other myeloid cells, recovered from the lung showed long-term modifications of their surface marker phenotype. The remodeling of alveolar macrophages was (a) long-lasting (still observed 6 months after infection), (b) regionally localized (observed only in the affected lobe after lobar pneumonia), and (c) associated with macrophage-dependent enhanced protection against another pneumococcal serotype. Metabolomic and transcriptomic profiling revealed that alveolar macrophages of mice that recovered from pneumonia had new baseline activities and altered responses to infection that better resembled those of adult humans. The enhanced lung protection after mild and self-limiting bacterial respiratory infections includes a profound remodeling of the alveolar macrophage pool that is long-lasting; compartmentalized; and manifest across surface receptors, metabolites, and both resting and stimulated transcriptomes.

Authors

Antoine Guillon, Emad I. Arafa, Kimberly A. Barker, Anna C. Belkina, Ian Martin, Anukul T. Shenoy, Alicia K. Wooten, Carolina Lyon De Ana, Anqi Dai, Adam Labadorf, Jaileene Hernandez Escalante, Hans Dooms, Hélène Blasco, Katrina E. Traber, Matthew R. Jones, Lee J. Quinton, Joseph P. Mizgerd

×

Figure 1

Murine model of self-limiting pneumonia.

Options: View larger image (or click on image) Download as PowerPoint
Murine model of self-limiting pneumonia.
To determine effects of acute p...
To determine effects of acute pneumonia, mice were infected with 106 CFU of serotype 19F instilled into the left lung lobe on day 0. To establish heterotypic immune protection, mice received a second infection with 106 CFU of serotype 19F instilled into the left lung lobe on day 7 and then were rested for 30 more days before lungs were examined. Sterile saline was used as control. Infected mice and controls were compared for (A) bacterial burden, (B) body weight, (C) gross morphology of lungs, and (D) leukocyte count in BAL, enumerated using a LUNA automated cell counter followed by a differential determined morphologically from cytocentrifuge preparations of BAL cells. In A, every individual symbol represents a single mouse, with horizontal lines showing median values for the group, and asterisks (*) indicate statistically significant (P < 0.05) differences from day 1 values using the Kruskal-Wallis test and Dunn’s post hoc multiple-comparisons test. In B, box and whisker plots show median, quartiles, and range, with asterisks (*) indicating significance (P < 0.05) of difference between saline and pneumococcus groups as determined using 2-way ANOVA and Holm-Šídák post hoc multiple-comparisons tests. In D, summary data show mean and SEM, with significance (P < 0.05) of difference from day 0 determined using 2-way ANOVA and Holm-Šídák post hoc multiple-comparisons test and communicated with letters representing cell type (T, total; N, neutrophils; M, macrophages). For B and D, pooled data represent a total n of 5–12 mice per group. For all, 2 independent experiments were performed. LOD, limit of detection.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts